Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Piétu

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Biotechniques|November 26, 1999
Reverse transcription in the presence of dideoxynucleotides to increase the sensitivity of expression monitoring with cDNA arraysC Decraene, I Reguigne-Arnould, C Auffray, et al.
Mayo Clinic Proceedings|May 1, 1991
von Willebrand factor: structure and functionD Meyer, G Piétu, E Fressinaud, et al.
Biochemical and Biophysical Research Communications|August 30, 1989
Localization within the 106 N-terminal amino acids of von Willebrand factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIIIG Piétu, A S Ribba, P Meulien, et al.
Case Reports in Orthopedics|March 3, 2017
Pectoralis Major Tear with Retracted Tendon: How to Fill the Gap? Reconstruction with Hamstring Autograft and Fixation with an Interference ScrewL Baverel, K Messedi, G Piétu, et al.
Biotechniques|March 1, 1994
Effect of plasmid size on transformation efficiency by electroporation of Escherichia coli DH5 alphaV Siguret, A S Ribba, G Chérel, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|December 3, 2014
External fixation of distal femoral fractures in adults' multicentre retrospective study of 43 patientsL Bedes, P Bonnevialle, M Ehlinger, et al.
British Journal of Haematology|May 1, 1994
Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domainS Jorieux, C Gaucher, G Piétu, et al.
Thrombosis and Haemostasis|August 30, 1988
Haemophilia A in a female: study of a family using intragenic and extragenic restriction site polymorphismsG Piétu, N Thomas-Maison, P Sié, et al.
British Journal of Haematology|May 1, 1995
A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand diseaseO Christophe, C Rouault, B Obert, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|December 3, 2014
Unicondylar fractures of the distal femurJ-C Bel, C Court, A Cogan, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Biotechniques|November 26, 1999
Reverse transcription in the presence of dideoxynucleotides to increase the sensitivity of expression monitoring with cDNA arraysC Decraene, I Reguigne-Arnould, C Auffray, et al.
Mayo Clinic Proceedings|May 1, 1991
von Willebrand factor: structure and functionD Meyer, G Piétu, E Fressinaud, et al.
Biochemical and Biophysical Research Communications|August 30, 1989
Localization within the 106 N-terminal amino acids of von Willebrand factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIIIG Piétu, A S Ribba, P Meulien, et al.
Case Reports in Orthopedics|March 3, 2017
Pectoralis Major Tear with Retracted Tendon: How to Fill the Gap? Reconstruction with Hamstring Autograft and Fixation with an Interference ScrewL Baverel, K Messedi, G Piétu, et al.
Biotechniques|March 1, 1994
Effect of plasmid size on transformation efficiency by electroporation of Escherichia coli DH5 alphaV Siguret, A S Ribba, G Chérel, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|December 3, 2014
External fixation of distal femoral fractures in adults' multicentre retrospective study of 43 patientsL Bedes, P Bonnevialle, M Ehlinger, et al.
British Journal of Haematology|May 1, 1994
Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domainS Jorieux, C Gaucher, G Piétu, et al.
Thrombosis and Haemostasis|August 30, 1988
Haemophilia A in a female: study of a family using intragenic and extragenic restriction site polymorphismsG Piétu, N Thomas-Maison, P Sié, et al.
British Journal of Haematology|May 1, 1995
A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand diseaseO Christophe, C Rouault, B Obert, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|December 3, 2014
Unicondylar fractures of the distal femurJ-C Bel, C Court, A Cogan, et al.
Pageof 5